BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

470 related articles for article (PubMed ID: 21315633)

  • 1. Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.
    Tan A; Etit D; Bayol U; Altinel D; Tan S
    Ann Diagn Pathol; 2011 Apr; 15(2):108-16. PubMed ID: 21315633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokeratin 19 immunoreactivity in the diagnosis of papillary thyroid carcinoma: a note of caution.
    Sahoo S; Hoda SA; Rosai J; DeLellis RA
    Am J Clin Pathol; 2001 Nov; 116(5):696-702. PubMed ID: 11710686
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-molecular-weight cytokeratin and cytokeratin-19 in the diagnosis of thyroid tumors.
    Raphael SJ; McKeown-Eyssen G; Asa SL
    Mod Pathol; 1994 Apr; 7(3):295-300. PubMed ID: 7520169
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of Twist in papillary thyroid carcinomas and its roles in differential diagnosis].
    He CN; He L; Cheng JQ; Chen SC; Zhao HF; Zhai JP; Zhang J
    Zhonghua Bing Li Xue Za Zhi; 2008 Jan; 37(1):35-9. PubMed ID: 18509983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors.
    Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV
    Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of cd56 and e-cadherin expression in the differential diagnosis of papillary thyroid carcinoma and suspected follicular-patterned lesions of the thyroid: the prognostic importance of e-cadherin.
    Ceyran AB; Şenol S; Şimşek BÇ; Sağıroğlu J; Aydın A
    Int J Clin Exp Pathol; 2015; 8(4):3670-80. PubMed ID: 26097548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improvement of the cytological diagnostic accuracy of follicular thyroid lesions by the use of the Ki-67 proliferative index in addition to cytokeratin-19 and HBME-1 immunomarkers: a study of 61 cases of liquid-based FNA cytology with histological controls.
    Lacoste-Collin L; d'Aure D; Bérard E; Rouquette I; Delisle MB; Courtade-Saïdi M
    Cytopathology; 2014 Jun; 25(3):160-9. PubMed ID: 24460983
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid transcription factor-1, thyroglobulin, cytokeratin 7, and cytokeratin 20 in thyroid neoplasms.
    Bejarano PA; Nikiforov YE; Swenson ES; Biddinger PW
    Appl Immunohistochem Mol Morphol; 2000 Sep; 8(3):189-94. PubMed ID: 10981870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohistochemical diagnosis of papillary thyroid carcinoma.
    Cheung CC; Ezzat S; Freeman JL; Rosen IB; Asa SL
    Mod Pathol; 2001 Apr; 14(4):338-42. PubMed ID: 11301350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunohistochemical study of papillary thyroid carcinoma and possible papillary thyroid carcinoma-related benign thyroid nodules.
    Mai KT; Ford JC; Yazdi HM; Perkins DG; Commons AS
    Pathol Res Pract; 2000; 196(8):533-40. PubMed ID: 10982016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytokeratin 19 and galectin-3 immunohistochemistry in the differential diagnosis of solitary thyroid nodules.
    Beesley MF; McLaren KM
    Histopathology; 2002 Sep; 41(3):236-43. PubMed ID: 12207785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histological and immunohistochemical aspects of papillary thyroid cancer.
    Radu TG; Mogoantă L; Busuioc CJ; Stănescu C; Grosu F
    Rom J Morphol Embryol; 2015; 56(2 Suppl):789-95. PubMed ID: 26429174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical subclassification of thyroid tumors with a prominent hyalinizing trabecular pattern.
    Lee S; Hong S; Koo JS
    APMIS; 2011 Aug; 119(8):529-36. PubMed ID: 21749453
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoexpression of HBME-1, high molecular weight cytokeratin, cytokeratin 19, thyroid transcription factor-1, and E-cadherin in thyroid carcinomas.
    Choi YL; Kim MK; Suh JW; Han J; Kim JH; Yang JH; Nam SJ
    J Korean Med Sci; 2005 Oct; 20(5):853-9. PubMed ID: 16224162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Expression of cytokeratin19, galectin-3 and HBME-1 in thyroid lesions and their differential diagnoses].
    Teng XD; Wang LJ; Yao HT; Li J; Ding W; Yan LP
    Zhonghua Bing Li Xue Za Zhi; 2004 Jun; 33(3):212-6. PubMed ID: 15256110
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic utility of thyroid transcription factors Pax8 and TTF-2 (FoxE1) in thyroid epithelial neoplasms.
    Nonaka D; Tang Y; Chiriboga L; Rivera M; Ghossein R
    Mod Pathol; 2008 Feb; 21(2):192-200. PubMed ID: 18084247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of immunohistochemistry in the differential diagnosis of thyroid gland tumors with follicular growth pattern].
    Laco J; Ryska A
    Cesk Patol; 2006 Jul; 42(3):120-4. PubMed ID: 16955558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Application value of fine needle aspiration and cell block in preoperative diagnosis of thyroid cancer and discrimination of follicular tumor].
    Fang Q; Cai C; Chen H
    Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2015 Aug; 50(8):668-72. PubMed ID: 26696207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cytokeratin expression of benign and malignant epithelial thyroid gland tumors. An immunohistologic study of 154 neoplasms using 8 different monoclonal cytokeratin antibodies].
    Schröder S; Wodzynski A; Padberg B
    Pathologe; 1996 Nov; 17(6):425-32. PubMed ID: 9082363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is BECLIN-1 Immunoreactivity More Effective than HBME-1 in Diagnosis of Papillary Thyroid Cancer?
    Yeşil C; Kandemir O; Haksever H; Dabakoğlu T
    Acta Chir Belg; 2015; 115(4):299-305. PubMed ID: 26324033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.